OxyContin 120mg modified-release tablets
BNF presentation 0407020ADBCAFAP within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020ADBCAFAP
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
50
NHS spend (£)
£9,030.02
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 7 |
| November 2024 | 1 |
| October 2024 | 4 |
| August 2024 | 1 |
| July 2024 | 6 |
| July 2021 | 4 |
| December 2020 | 9 |
| November 2020 | 18 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 15 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
|
The Mortimer Medical Prac
ODS M81043
|
3 | 18C - HEREFORDSHIRE & WORCESTERSHIRE ICB |
| Unknown pharmacy | 3 | No data available |
|
Health Care First Partnership
ODS B87030
|
2 | 03R - WEST YORKSHIRE ICB |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |